Ultrasound used to predict heart attack riskAugust 19, 2008OAK BROOK, Ill. - Repeat exams using widely available and inexpensive ultrasound imaging could help identify patients at high risk for a heart attack or other adverse cardiovascular events, according to a study published in the September issue of the journal Radiology. Researchers performed ultrasound imaging on the carotid arteries of 1,268 patients who were asymptomatic but at high risk for cardiovascular disease. Of those, ultrasound determined that 574 patients had carotid artery disease, as determined by the amount of plaque built up in the two vessels that supply blood to the head and neck. Each of those patients had a second ultrasound exam six to nine months later to measure changes in the plaque lining the arteries. "Determining the degree of stenosis, or how much the artery has narrowed, is insufficient to predict patient risk," said lead researcher Markus Reiter, M.D., from the Department of Angiography and Interventional Radiology at Medical University Vienna in Austria. "We know that the majority of cardiovascular and cerebrovascular events occur in patients whose blood vessels are less than 70 percent narrowed."
Reiter and his team used ultrasound images and computer-assisted gray scale median (GSM) measurements to determine the density of the plaque lining the carotid arteries. Plaques that appear dark on ultrasound images and have a low GSM level are suggested to be associated with an increased risk for clinical complications and seem to represent unstable plaques, which are more likely to rupture or burst. The study's follow-up ultrasounds revealed that GSM levels had decreased in 230 (40 percent) of the patients. Of those, 85 (37 percent) experienced a major adverse cardiovascular event within three years of the second ultrasound. Examples of these events include heart attack, stroke, coronary artery bypass, surgery or other intervention. In 344 (60 percent) of the patients, ultrasound GSM levels had increased between the baseline and follow-up ultrasound examinations. Of those patients, 92 (28 percent) experienced a major adverse cardiovascular event. "Patients with a reduction in GSM levels from their baseline ultrasound to the follow-up ultrasound exhibited a significantly increased risk for near-future adverse event compared to patients with increasing GSM levels," said Dr. Reiter. It is important to note that the results showed that vulnerable plaque in the carotid artery was not only an indicator of increased risk of stroke downstream from the carotid artery, but also was associated with disease progression elsewhere in the cardiovascular system. Although additional studies are needed, Dr. Reiter said measuring GSM levels on serial ultrasound examinations may be a noninvasive way to identify the presence of vulnerable plaques and improve the effectiveness of therapeutic strategies. "This technique will give us additional information to use in selecting patients that need aggressive treatment," he said. Radiological Society of North America | |||||||||||||||||||||
|
Related Ultrasound Current Events and Ultrasound News Articles Microarray analysis improves prenatal diagnosis A "chip" or array that can quickly detect disorders such as Down syndrome or other diseases associated with chromosomal abnormalities proved an effective tool in prenatal diagnosis in a series of 300 cases at Baylor College of Medicine, said researchers in a report that appears in the current issue of the journal Prenatal Diagnosis. Low risk for heart attack? Could an ultrasound hold the answer? By adding the results of an imaging technique to the traditional risk factors for coronary heart disease, doctors at Baylor College of Medicine in Houston found they were able to improve prediction of heart attacks in people previously considered low risk. New technology could revolutionize breast cancer screening The world's first radar breast imaging system developed at Bristol University that could revolutionise the way women are scanned for breast cancer, is being trialled at North Bristol NHS Trust (NBT). Computer model improves ultrasound image Doctors use diagnostic sonography or ultrasound to visualise organs and other internal structures of the human body. Ultrasound shown to exert remote control of brain circuits In a twist on nontraditional uses of ultrasound, a group of neuroscientists at Arizona State University has developed pulsed ultrasound techniques that can remotely stimulate brain circuit activity. Jefferson Department of Surgery announces new pancreas tumor registry Charles J. Yeo, M.D., Samuel D. Gross Professor and Chair, Department of Surgery at Jefferson Medical College of Thomas Jefferson University, announces the establishment of the new Jefferson Pancreas Tumor Registry (JPTR). Researchers propose new ultrasound screening criteria for diagnosing polycystic kidney disease Modification of the current screening criteria are needed for diagnosing patients with autosomal dominant polycystic disease (ADPKD), according to a study appearing in the January 2009 issue of the Journal of the American Society Nephrology (JASN). The results suggest that some patients with a milder form of the disease may otherwise be misdiagnosed. 3-D doppler ultrasound helps identify breast cancer Three-dimensional (3-D) power Doppler ultrasound helps radiologists distinguish between malignant and benign breast masses, according to a new study being published in the November issue of Radiology. New devices used to reduce arterial occlusions, provide cardiac support, highlighted at TCT 2008 Research results highlighting three new devices used to reduce blockages in peripheral and coronary arteries and to provide cardiac support will be presented at the 20th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation (CRF). Drug may reduce coronary artery plaque Research presented at the 20th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation (CRF), suggests that olmesartan, a drug commonly used to treat high blood pressure, may play a role in reducing coronary plaque. More Ultrasound Current Events and Ultrasound News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||